U.S. NEUROPATHIC PAIN TREATMENT MARKET ANALYSIS

U.S. Neuropathic Pain Treatment Market, by Drug Type (Pain Relievers (NSAIDS, Opioids (Tramadol, Oxycodone, and Others)), Anti-seizure Medications (Gabapentin, Pregabalin, and Others), Topical Treatments, Antidepressants (Duloxetine, Amitriptyline, Escitalopram, and Others), and Others), by Indication (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Dec 2022
Code : CMI5429
Pages :155
Formats :
Excel and PDF
Industry : Pharmaceutical

U.S. Neuropathic Pain Treatment MarketSize and Trends

U.S. Neuropathic Pain Treatment Market Report Coverage

U.S. neuropathic pain treatment market is estimated to be valued at US$ 2,064.9 Mn in 2022 and is expected to exhibit a CAGR of 4.8% over the forecast period (2022-2030).

Figure 1: U.S. Neuropathic Pain Treatment Market Share (%) Analysis, By Drug Type, 2022

Figure 2: U.S. Neuropathic Pain Treatment Market Value (US$ Mn) Analysis and Forecast and Y-o-Y Growth (%), 2017-2030

U.S. Neuropathic Pain Treatment Market Report Snapshots

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Press Release

U.S. Neuropathic Pain Treatment Market to Surpass US$ 2,994.0 Mn by 2030

Credibility and Certifications

9001:2015

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients